Programmed to Die

James King-Holmes/Science Photo Library Predicting natural death is generally impossible, save for those who study Caenorhabditis elegans: They know the precise moment that 131 cells, and only those 131 cells, are programmed to die. The timing and location of cell death is identical during the development of every tiny C. elegans worm. Nobel laureates John Sulston and Robert Horvitz discovered these cellular suicides in 1976 when they mapped the fate of C. elegans' 1,090 cells. "It really di

Written byLaura Defrancesco
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Predicting natural death is generally impossible, save for those who study Caenorhabditis elegans: They know the precise moment that 131 cells, and only those 131 cells, are programmed to die. The timing and location of cell death is identical during the development of every tiny C. elegans worm. Nobel laureates John Sulston and Robert Horvitz discovered these cellular suicides in 1976 when they mapped the fate of C. elegans' 1,090 cells.

"It really did jump out," recalls Sulston. "We had no idea that we were going to be able to see [cell death], and that it would be one of the cell fates, being absolutely determined by the origin of the cell." That map, which is still the only complete cartography of a whole organism, spawned the field of programmed cell-death research, known as apoptosis, and highlights how important the regulation of cell death is to normal life.

DEADLY ORIGINS ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies